title: Orexin/hypocretin in psychiatric disorders: present state of knowledge and future potential.
authors.affiliation: Department of Anesthesiology, Pharmacology & Therapeutics, University of British Columbia, Vancouver, BC, Canada. borgland@interchange.ubc.ca
authors.forename: Stephanie L
authors.initials: SL
authors.lastname: Borgland
authors.forename: Gwenaël
authors.initials: G
authors.lastname: Labouèbe
mesh_terms: D001921:Brain / Q000378:metabolism; D003866:Depressive Disorder / Q000188:drug therapy / Q000378:metabolism; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000378:metabolism*; D001523:Mental Disorders / Q000188:drug therapy / Q000378:metabolism*; D009479:Neuropeptides / Q000378:metabolism*; D000068797:Orexins; D012559:Schizophrenia / Q000188:drug therapy / Q000378:metabolism; D019966:Substance-Related Disorders / Q000188:drug therapy / Q000378:metabolism
chemical_list: D047908:Intracellular Signaling Peptides and Proteins; D009479:Neuropeptides; D000068797:Orexins